Market Tracker

07/30 6:05pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

163.68
Data as of Jul 30
 -0.10 / -0.06%
Today’s Change
100.89
Today|||52-Week Range
185.43
+23.18%
Year-to-Date

Today’s Trading

Previous close163.78
Today’s open164.90
Day’s range162.66 - 167.76
Volume936,143
Average volume (3 months)1,205,149
Market cap$32.4B
Dividend yield--
Data as of 3:59pm ET, 07/30/2014

Growth & Valuation

Earnings growth (last year)-0.78%
Earnings growth (this year)+62.98%
Earnings growth (next 5 years)+28.55%
Revenue growth (last year)+34.85%
P/E ratio82.7
Price/Sales17.19
Price/Book13.54

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...+2.13+1.72%
VRTXVertex Pharmaceutica...-3.55-3.71%
PRGOPerrigo Company PLC-0.75-0.48%
MYLMylan Inc+0.15+0.30%
Data as of 4:07pm ET, 07/30/2014

Financials

Last reporting dateJuly 24, 2014
EPS forecast (this quarter)$1.11
Annual revenue (last year)$1.5B
Annual profit (last year)$252.9M
Net profit margin16.73%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, Treasurer &
Director
Leonard Bell
Chief Global Operations Officer &
Executive VP
Stephen P. Squinto
Corporate headquarters
Cheshire, Connecticut

Forecasts